Novo Nordisk A/S Common Stock (NVO) stock — price, news and analysis
Novo Nordisk A/S Common Stock (NVO) trades on NYSE. OneDayTrading is tracking 7 recent stories on NVO — 4 bullish and 2 bearish — alongside its live price and interactive chart below.
Catalystsby D-day
FOMC = U.S. Fed official schedule · expiry = US options/futures (3rd Friday)
Latest NVO news
Novo Nordisk, post-Wegovy plan meets a 2032 patent cliff
Sep 21, 2026
Novo Nordisk rebrands to Novo as obesity-market share gap with Lilly widens
Sep 14, 2026
Novo Nordisk, STEP Young Opens a Pediatric Test for Wegovy
Sep 13, 2026
Medicare GLP-1 Coverage Starts July 1: LLY, NVO and the Awareness Gap
Jun 29, 2026
CVS Stock: Why One Top Analyst Sees 9,000 Pharmacies as a GLP-1 Buy Signal
Jun 28, 2026
Medicare Opens GLP-1 Weight-Loss Coverage July 1: What It Means for LLY, NVO
Jun 28, 2026
Zealand Pharma (ZLDPF) Stock Swings Signal Amylin Pivot in Weight-Loss Race vs LLY, NVO
Jun 19, 2026Related stocks
Tickers frequently mentioned alongside NVO in recent news.
NVO — frequently asked
What is the NVO stock price today?
The live Novo Nordisk A/S Common Stock (NVO) price and an interactive chart are shown at the top of this page, updated in real time during US market hours (9:30 AM – 4:00 PM ET) and at the last close otherwise.
Where is NVO listed?
Novo Nordisk A/S Common Stock (NVO) is listed on NYSE. It belongs to the 제약 sector.
Is the latest NVO news bullish or bearish?
Of the 7 recent NVO stories we track, 4 are bullish, 2 bearish and 1 neutral. See the news section below for details.
Prices are delayed outside US market hours and provided for information only — not investment advice. Novo Nordisk A/S Common Stock (NVO) news is produced from public information.